Fitzgibbon Marian L, Ferreira M Rosario, Dolan Nancy C, Davis Terry C, Rademaker Alfred W, Wolf Michael S, Liu Dachao, Gorby Nicolle, Schmitt Brian P, Bennett Charles L
University of Illinois at Chicago, Section of Health Promotion Research, Department of Medicine, IL 60608, USA.
Health Promot Pract. 2007 Jul;8(3):273-81. doi: 10.1177/1524839907302210.
Colorectal cancer (CRC) is the third most common cancer in the United States. Although CRC screening is recommended for individuals 50 years and older, screening completion rates are low. This can be attributed to provider and patient barriers. We developed an intervention to improve provider recommendation and patient screening among noncompliant male veterans in a 2-year randomized controlled trial and examined the relationship between participation and study outcomes among patients and providers. Overall, providers who attended intervention sessions recommended CRC screening during 64% of patient visits and providers who did not attend any intervention sessions recommended screening during 54% of visits (p < .01). Patients of providers who attended intervention sessions also were more likely to be screened (42% versus 29%, p < .05). The patient intervention did not have the desired impact. The subgroup of patients in the patient intervention was not more likely to complete CRC screening.
结直肠癌(CRC)是美国第三大常见癌症。尽管建议50岁及以上人群进行CRC筛查,但筛查完成率较低。这可归因于医疗服务提供者和患者面临的障碍。在一项为期2年的随机对照试验中,我们开发了一种干预措施,以提高不符合要求的男性退伍军人中医疗服务提供者的推荐率和患者的筛查率,并研究了患者和医疗服务提供者的参与情况与研究结果之间的关系。总体而言,参加干预课程的医疗服务提供者在64%的患者就诊时推荐了CRC筛查,而未参加任何干预课程的医疗服务提供者在54%的就诊时推荐了筛查(p < 0.01)。参加干预课程的医疗服务提供者的患者也更有可能接受筛查(42%对29%,p < 0.05)。患者干预没有产生预期效果。接受患者干预的患者亚组完成CRC筛查的可能性并不更高。